Are drugs for rare diseases "essential"?

被引:10
作者
Reidenberg, Marcus M. [1 ]
机构
[1] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
关键词
D O I
10.2471/BLT.06.0034447
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:686 / 686
页数:1
相关论文
共 7 条
[1]  
Beauchamp TL, 1979, PRINCIPLES BIOMEDICA, DOI DOI 10.1016/S0035-9203(02)90063-5
[2]  
*CTR DRUG EV RES U, BRIEF HIST CTR DRUG
[3]   25 years of the WHO essential medicines lists: progress and challenges [J].
Laing, R ;
Waning, B ;
Gray, A ;
Ford, N ;
't Hoen, E .
LANCET, 2003, 361 (9370) :1723-1729
[4]   What has been the impact of the concept of essential drugs? [J].
Levy, M ;
Reidenberg, MM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (04) :275-278
[5]   Rare essentials: drugs for rare diseases as essential medicines [J].
Stolk, Pieter ;
Willemen, Marjolein J. C. ;
Leufkens, Hubert G. M. .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2006, 84 (09) :745-751
[6]   FOUNDATIONS OF COST-EFFECTIVENESS ANALYSIS FOR HEALTH AND MEDICAL PRACTICES [J].
WEINSTEIN, MC ;
STASON, WB .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (13) :716-721
[7]  
OFFICE RARE DIS NATL